Literature DB >> 10767858

Therapeutic trials in childhood ALL: what's their future?

O B Eden1.   

Abstract

Mesh：

Year:  2000        PMID： 10767858      PMCID： PMC1731071          DOI： 10.1136/jcp.53.1.55

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  45 in total

1.  Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study Group.

Authors:  A Borkhardt; G Cazzaniga; S Viehmann; M G Valsecchi; W D Ludwig; L Burci; S Mangioni; M Schrappe; H Riehm; F Lampert; G Basso; G Masera; J Harbott; A Biondi
Journal:  Blood       Date:  1997-07-15       Impact factor: 22.113

2.  In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia.

Authors:  G J Kaspers; A J Veerman; R Pieters; C H Van Zantwijk; L A Smets; E R Van Wering; A Van Der Does-Van Den Berg
Journal:  Blood       Date:  1997-10-01       Impact factor: 22.113

3.  Clearance of marrow infiltration after 1 week of therapy for childhood lymphoblastic leukaemia: clinical importance and the effect of daunorubicin. The Medical Research Council's Working Party on Childhood Leukaemia.

Authors:  J S Lilleyman; B E Gibson; R F Stevens; A M Will; I M Hann; S M Richards; F G Hill
Journal:  Br J Haematol       Date:  1997-06       Impact factor: 6.998

4.  Philadelphia chromosome-positive acute lymphoblastic leukemia in children: durable responses to chemotherapy associated with low initial white blood cell counts.

Authors:  R C Ribeiro; A Broniscer; G K Rivera; M L Hancock; S C Raimondi; J T Sandlund; W Crist; W E Evans; C H Pui
Journal:  Leukemia       Date:  1997-09       Impact factor: 11.528

5.  Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.

Authors:  J M Chessels; G J Swansbury; B Reeves; C C Bailey; S M Richards
Journal:  Br J Haematol       Date:  1997-10       Impact factor: 6.998

6.  Treatment related deaths during induction and in first remission in acute lymphoblastic leukaemia: MRC UKALL X.

Authors:  K Wheeler; J M Chessells; C C Bailey; S M Richards
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

7.  Meta-analyses of randomised trials: when the whole is more than just the sum of the parts.

Authors:  M K Parmar; L A Stewart; D G Altman
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

Review 8.  Biology and treatment of infant leukemias.

Authors:  C H Pui; J R Kane; W M Crist
Journal:  Leukemia       Date:  1995-05       Impact factor: 11.528

9.  Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.

Authors:  M Smith; D Arthur; B Camitta; A J Carroll; W Crist; P Gaynon; R Gelber; N Heerema; E L Korn; M Link; S Murphy; C H Pui; J Pullen; G Reamon; S E Sallan; H Sather; J Shuster; R Simon; M Trigg; D Tubergen; F Uckun; R Ungerleider
Journal:  J Clin Oncol       Date:  1996-01       Impact factor: 44.544

10.  Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group.

Authors:  P G Steinherz; P S Gaynon; J C Breneman; J M Cherlow; N J Grossman; J H Kersey; H S Johnstone; H N Sather; M E Trigg; R Chappell; D Hammond; W A Bleyer
Journal:  J Clin Oncol       Date:  1996-02       Impact factor: 44.544
View more
  1 in total

1.  New methods to assess 6-thiopurine toxicity and expanding its therapeutic application to pancreatic cancer via small molecule potentiators.

Authors:  Chamitha Weeramange; Ashabha Lansakara; Johnathan Dallman; Thi Nguyen; Wasundara Hulangamuwa; Ryan J Rafferty
Journal:  Medchemcomm       Date:  2019-03-18       Impact factor: 3.597
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.